Table 2.
Gene symbol, name, and DNA-repair pathway | Chromosomal location | dbSNP ID | Nucleotide Change | Amino Acid change, or UTR | Functionality Prediction | HapMap (CEU)a MAF (%) | 1000 Genomes (EUR)b MAF (%) | MAF in this study (%) | HWE p value | |
---|---|---|---|---|---|---|---|---|---|---|
ALKBH1 | Alkylation Repair Homolog 1, De-Alkylation pathway | 14q24.3 | rs17825440 | T>C | Non-syn, M135I | Tolerated | 4 | 2 | 0 | – |
rs6494 | A>T | Non-syn M324L | Tolerated | 26 | 24 | 16 | 0.74 | |||
APEX1 | (APEX nuclease (multifunctional DNA-repair enzyme) 1) Base Excision Repair Pathway | rs1760944 | T>G | Utr-51 | No direct binding | 43 | 35 | 46 | 0.66 | |
rs3136814 | C>A | Utr-51 | Tolerated | 3 | 4 | 4 | 0.002 | |||
rs3136817 | C>T | Intron | No miRNA binding | 22 | 29 | 19 | 0.23 | |||
rs1130409 | G>T | Non-syn, D148E | 46 | 49 | 44 | 0.01 | ||||
rs4585 | G>T | utr-31 | 47 | 38 | – | – | ||||
ATM | Ataxia Telangiectasia Mutated, Homologous recombination pathway | 11q22–q23 | rs592955 | A>C | utr-51 | No direct binding | 43 | 38 | 49 | 0.8 |
rs609261 | T>C | utr-51 | Possibly damaging | 49 | 38 | 49 | 0.9 | |||
rs1801516 | T>C | non-syn, D1853N | Tolerated | 17 | 16 | 8 | 0.3 | |||
BRCA1 | Breast Cancer 1, Early Onset, Homologous recombination pathway | 17q21.31 | rs1799966 | C>T | Non-syn, S1613C | Damaging | 34 | 35 | 32 | 0.38 |
rs28897687 | C>A | Non-syn, N1236K | Damaging | 1.1 | 0 | – | – | |||
rs4986852 | T>C | Non-syn, S1040N | Damaging | 5 | 2 | 0 | – | |||
rs4986850 | T>C | Non-Syn, D693N | Damaging | 10 | 8 | 4 | 0.05 | |||
EXO1 | Exonuclease 1, Homologous recombination and Mismatch repair pathways | 1q42–q43 | rs1776177 | C>T | Non-syn, | Not found | 49 | 46 | 48 | 0.74 |
rs1776179 | C>T | Non-syn | Not Found | 27 | 31 | 27 | 0.15 | |||
rs735943 | A>G | Non-syn, H354R | Tolerated | 42 | 42 | 34 | 0.302 | |||
rs4149963 | T>C | Non-Syn, T439M | Tolerated | 7 | 8 | 8 | 0.004 | |||
rs4149965 | A>G | Non-Syn, V458M | Tolerated | 30 | 25 | 12 | 0.94 | |||
rs1047840 | A>G | Non-syn, | Not found | 39 | 37 | 43 | 0.78 | |||
rs1776148 | A>G | Non-Syn, E670G | Tolerated | 35 | 34 | 29 | 0.401 | |||
rs9350 | T>C | Non-Syn, P757L | Damaging | 15 | 15 | 25 | 0.186 | |||
FAN1 | Fanconi-Associated Nuclease 1 Homologous recombination pathway | 14q11.2 | rs6493352 | T>C | Non Syn, R648H | Tolerated | 17 | 18 | 20 | 0.58 |
FANCD2 | Fanconi Anemia, Complementation Group D2 Homologous recombination pathway | 3p25.3 | rs9845756 | T>C | Utr-51 | Possibly damaging | 20 | 13 | 0 | – |
rs3172417 | T>C | Utr-31 | 39 | 45 | 23 | 0.17 | ||||
Lig1 | Ligase I, DNA, ATP-Dependent, Base Excision Repair Pathway | 19q13.33 | rs20580 | A>G | Utr-51 | No direct binding | 46 | 49 | 42 | 0.72 |
rs3730842 | C>T | Coding-syn | Not found | 13 | 10 | 20 | 0.56 | |||
Lig4 | ligase IV, DNA, ATP-dependent, Base Excision Repair Pathway | 13q33.3 | rs1805388 | A>G | Missense, T9I | Damaging | 19 | 16 | 15 | 0.84 |
MGMT | O-6-Methylguanine-DNA Methyltransferase,De-Alkylation pathway | 10q26.3 | rs10764881 | A>G | Near-gene-51 | No direct binding | 37 | 30 | 19 | 0.61 |
rs12917 | T>C | Non-syn, L115F | Damaging | 10 | 13 | 18 | 0.90 | |||
rs2308321 | G>A | Non syn, I174V | Tolerated | 16 | 13 | 7 | 0.49 | |||
rs2308327 | G>A | Non-syn, K209R | Tolerated | 9 | 13 | 10 | 0.34 | |||
rs113813075 | C>A | Utr-51 | 5 | 6 | ||||||
MRE11 | Meiotic Recombination 11 Homolog A, Homologous recombination pathway | 11q21 | rs215509 | C>T | Utr-31 | 32 | 12 | 33 | 0.67 | |
rs533984 | A>G | Intron | 39 | 40 | 48 | 0.03 | ||||
rs1805363 | T>C | Utr-51 | 9 | 8 | 8 | 0.40 | ||||
NBN | Nijmegen Breakage Syndrome 1, Homologous recombination pathway | 8q21.3 | rs1805800 | T>C | Utr-51 | Not direct binding | 28 | 30 | – | – |
rs1805794 | G>C | Non-syn, E185Q | Tolerated | 31 | 30 | 0 | – | |||
rs2735383 | G>C | Utr-31 | 32 | 29 | 37 | 0.06 | ||||
RAD50 | RAD50 homolog, Homologous recombination pathway | 5q31.1 | rs3798135 | T>C | Intron | 21 | 19 | 25 | 0.30 | |
rs2522403 | C>T | Intron | 22 | 19 | 31 | 0.05 | ||||
rs10520114 | G>A | Intron | 22 | 18 | 16 | 0.27 | ||||
RAD51 | RAD51 Recombinase, Homologous recombination pathway | 15q15.1 | rs2619679 | T>A | Utr-3 | 47 | 49 | 42 | 0.23 | |
rs7180135 | G>A | Utr-3 | Not found | 47 | 43 | 27 | 0.55 | |||
rs1801321 | T>G | Non-syn, | 47 | 42 | 27 | 0.81 | ||||
RAD52 | RAD52 Homolog Homologous recombination pathway | 12p13.33 | rs7310449 | C>T | Utr-31 | 44 | 42 | 0 | – | |
rs7301931 | C>T | Utr-31 | 49 | 43 | 45 | 0.40 | ||||
rs11571475 | G>A | Utr-31 | 13 | 13 | 11 | 0.29 | ||||
RFC1 | Replication factor C, Mismatch Repair pathway | 4p14-p13 | rs6844176 | C>T | Intron | 38 | 43 | 48 | 0.38 | |
XRCC1 | X-Ray Repair Complementing Defective Repair In Chinese Hamster Cells, Base Excision Repair Pathway | 19q13.2 | rs25489 | T>C | Missense, R280H | damaging | 10 | 5 | 3 | 0.23 |
rs1799782 | A>G | Missense, R194W | damaging | 12 | 5 | 12 | 0.43 | |||
rs25487 | T>C | Missense, Q399R | damaging | 23 | 36 | 26 | 0.78 |
aCEU-Utah residents of Northern and Western European Ancestry.
bEUR-European population including both Finnish and non-Finnish European subpopulations.
The in silico functional evaluation for the non-synonymous genetic variants were predicted using four different tools SIFT (https://sift.bii.a-star.edu.sg), Polyphen (http://genetics.bwh.harvard.edu/pph2/), SNPs3D (http://www.snps3d.org), and PANTHER (http://www.pantherdb.org). The functional importance of the SNPs within 5′ flanking regions was predicted by looking at potential transcriptional binding sites, which may affect transcription, using the MatInspector tool (www.genomatx.de). The same approach was performed for SNPs within 3′ UTR looking for miRNA sites using TargetScan Human 5.1 (http://www.targetscan).